🇺🇸 FDA
Pipeline program

Ferric derisomaltose

Monofer-HFpEF

Approved small_molecule active

Quick answer

Ferric derisomaltose for Heart Failure With Preserved Ejection Fraction is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Heart Failure With Preserved Ejection Fraction
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials